Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$384M |
| 2 |
Mondelez International
MDLZ
|
+$125M |
| 3 |
NVIDIA
NVDA
|
+$116M |
| 4 |
Johnson & Johnson
JNJ
|
+$105M |
| 5 |
Church & Dwight Co
CHD
|
+$55.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$276M |
| 2 |
Apple
AAPL
|
+$180M |
| 3 |
Duke Energy
DUK
|
+$75.7M |
| 4 |
ConocoPhillips
COP
|
+$73.6M |
| 5 |
Broadcom
AVGO
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.11% |
| 2 | Technology | 9.83% |
| 3 | Utilities | 6.25% |
| 4 | Real Estate | 4.8% |
| 5 | Consumer Discretionary | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAG
1351
DELISTED
MAG Silver
MAG
| $312K | ﹤0.01% |
+22,231
| New | +$293K |
|
1352
SSR Mining
SSRM
$7.73B
| $311K | ﹤0.01% |
54,748
-269,117
| -83% | -$1.41M |
|
1353
Genie Energy
GNE
$402M
| $308K | ﹤0.01% |
+18,951
| New | +$310K |
|
1354
Theravance Biopharma
TBPH
$883M
| $306K | ﹤0.01% |
38,018
-42,937
| -53% | -$372K |
|
1355
Camden National
CAC
$961M
| $305K | ﹤0.01% |
+7,382
| New | +$280K |
|
1356
Cadeler
CDLR
$2.32B
| $305K | ﹤0.01% |
10,816
+14
| +0.1% | +$363 |
|
1357
Southern California Bancorp
BCAL
$688M
| $304K | ﹤0.01% |
+20,551
| New | +$299K |
|
1358
Global Industrial
GIC
$1.53B
| $304K | ﹤0.01% |
8,957
-23,443
| -72% | -$771K |
|
1359
SiteOne Landscape Supply
SITE
$4.17B
| $303K | ﹤0.01% |
2,011
-7,179
| -78% | -$984K |
|
1360
Kiniksa Pharmaceuticals
KNSA
$6.2B
| $298K | ﹤0.01% |
+11,938
| New | +$291K |
|
1361
Liquidia Corp
LQDA
$6.31B
| $297K | ﹤0.01% |
+29,743
| New | +$325K |
|
1362
Stoneridge
SRI
$205M
| $296K | ﹤0.01% |
26,486
+3,920
| +17% | +$55.9K |
|
1363
Sundial Growers
SNDL
$338M
| $295K | ﹤0.01% |
143,018
+65,952
| +86% | +$138K |
|
1364
Hexcel
HXL
$6.98B
| $294K | ﹤0.01% |
4,755
-153,630
| -97% | -$9.66M |
|
1365
Compass Diversified
CODI
$867M
| $293K | ﹤0.01% |
+13,223
| New | +$288K |
|
1366
Extreme Networks
EXTR
$2.93B
| $293K | ﹤0.01% |
19,481
-472,224
| -96% | -$6.69M |
|
|
HBI
1367
DELISTED
Hanesbrands
HBI
| $293K | ﹤0.01% |
+39,803
| New | +$238K |
|
1368
Nerdy
NRDY
$89.7M
| $293K | ﹤0.01% |
+19,873
| New | +$382K |
|
1369
Janux Therapeutics
JANX
$1.15B
| $291K | ﹤0.01% |
+6,413
| New | +$279K |
|
1370
SEI Investments
SEIC
$13.4B
| $290K | ﹤0.01% |
+4,190
| New | +$280K |
|
|
ML
1371
DELISTED
MoneyLion Inc.
ML
| $290K | ﹤0.01% |
+6,976
| New | +$378K |
|
1372
Artesian Resources
ARTNA
$371M
| $289K | ﹤0.01% |
+7,776
| New | +$292K |
|
1373
Bank First Corp
BFC
$1.69B
| $289K | ﹤0.01% |
3,183
+553
| +21% | +$49K |
|
1374
Red Rock Resorts
RRR
$3.63B
| $289K | ﹤0.01% |
+5,315
| New | +$296K |
|
1375
Spyre Therapeutics
SYRE
$9.47B
| $286K | ﹤0.01% |
+9,733
| New | +$271K |
|
Similar funds
Michael Gelband's Q3 2024 Portfolio in Review
As of Q3 2024, Michael Gelband held 2,213 positions worth $16.4B, up 12% from $14.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Michael Gelband deployed $963M of net new capital in Q3 2024, opening 752 new positions and adding to 404 existing holdings. Its largest new stake was Mondelez International: 1,784,906 shares worth $131M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 10% a quarter earlier, followed by Technology and Utilities.
On the sell side, the largest reduction was ConocoPhillips, an estimated $73.6M trimmed.
- Michael Gelband's largest Q3 2024 buy was Mondelez International: 1,784,906 shares worth $131M.
- Michael Gelband added most to Microsoft in Q3 2024, an estimated $384M increase.
- Michael Gelband's biggest Q3 2024 reduction was ConocoPhillips, cutting an estimated $73.6M.
- Michael Gelband fully exited Amazon in Q3 2024, selling an estimated $276M.
- Michael Gelband's ten largest holdings make up 37% of its $16.4B portfolio in Q3 2024.
- Michael Gelband opened 752 new positions and closed 645 in Q3 2024.
- Michael Gelband's portfolio value rose 12% quarter-over-quarter to $16.4B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.